Company intelligence / Profile preview

inSeption Group

Audubon, Pennsylvania, United Statesinseptiongroup.com ↗

Ownership: Private
Development stage: Other

Overview

inSeption Group delivers full-service clinical outsourcing and consulting to biotech and pharma companies, with recognized expertise in oncology, neurodegenerative disorders, rare diseases, and cell/gene therapies. The company has been recognized for rapid growth and high-quality deliverables but does not publish its own clinical results as it operates as a CRO.

Therapeutic areas: OncologyRare DiseasesNeurologyHematology
Modalities: Cell therapyGene therapySmall moleculeBiologic
Industry: Contract Research Organization

Partnerships

Pennsylvania Biotechnology Center/B+Labs community partnership to support early-stage biotech companies with trial planning and development guidance.

Beyond the preview

Go deeper on inSeption Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inSeption Group.

Explore the full profile